1. OP0034 Efficacy and Safety of Mavrilimumab, A Fully Human Gm–CSFR-Alpha Monoclonal Antibody in Patients with Rheumatoid Arthritis: Primary Results from the Earth Explorer 1 Study. (9th June 2015) Authors: Burmester, G.R.; McInnes, I.B.; Kremer, J.M.; Miranda, P.; Korkosz, M.; Vencovsky, J.; Rubbert-Roth, A.; Mysler, E.; Sleeman, M.A.; Godwood, A.; Albulescu, M.; Close, D.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. (11th June 2017) Authors: Hepburn, L.; Hijnen, D.J.; Sellman, B.R.; Mustelin, T.; Sleeman, M.A.; May, R.D.; Strickland, I. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. (1st July 2017) Authors: Hepburn, L.; Hijnen, D.J.; Sellman, B.R.; Mustelin, T.; Sleeman, M.A.; May, R.D.; Strickland, I. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗